Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19

Viral infections and antiphospholipid antibodies

Uthman, I. W., & Gharavi, A. E. (2002) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2002.28303 · Cited by 302

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up

Bikdeli, B., Madhavan, M. V., Jiménez, D., Chuich, T., Dreyfus, I., Driggin, E., Der-Nigoghossian, C. A., Ageno, W., Madjid, M., Guo, Y., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.031 · Cited by 2,967

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Merad, M., & Martin, J. C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0331-4 · Cited by 2,472

Neurological associations of COVID-19

Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., Kneen, R., Defres, S., Sejvar, J., & Solomon, T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30221-0 · Cited by 2,156

Neutrophil extracellular traps in COVID-19

Zuo, Y., Yalavarthi, S., Shi, H., Gockman, K., Zuo, M., Madison, J. A., Blair, C., Weber, A. G., Barnes, B. J., Egeblad, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138999 · Cited by 1,598

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study

Varatharaj, A., Thomas, N., Ellul, M. A., Davies, N. W. S., Pollak, T. A., Tenorio, E. L., Sultan, M., Easton, A., Breen, G., Zandi, M., et al. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30287-x · Cited by 1,246

Classification of the cutaneous manifestations of COVID ‐19: a rapid prospective nationwide consensus study in Spain with 375 cases

Galván‐Casas, C., Català, A., Hernández, G. C., Rodríguez‐Jiménez, P., Fernández‐Nieto, D., Lario, A. R., Fernández, I. N., Ruíz‐Villaverde, R., Falkenhain‐López, D., Velasco, M. L., et al. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19163 · Cited by 1,230

Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia

Brann, D. H., Tsukahara, T., Weinreb, C., Lipovsek, M., Van den Berge, K., Gong, B., Chance, R., Macaulay, I. C., Chou, H.-J., Fletcher, R. B., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc5801 · Cited by 1,198

Angiotensin‐converting enzyme 2 ( ACE2 ), SARS‐CoV ‐2 and the pathophysiology of coronavirus disease 2019 ( COVID ‐19)

Bourgonje, A. R., Abdulle, A. E., Timens, W., Hillebrands, J., Navis, G. J., Gordijn, S. J., Bolling, M. C., Dijkstra, G. D. H., Voors, A. A., Osterhaus, A. D. M. E., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5471 · Cited by 1,160

Interplay between inflammation and thrombosis in cardiovascular pathology

Stark, K., & Massberg, S. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00552-1 · Cited by 1,033

COVID-19 and diabetes mellitus: from pathophysiology to clinical management

Lim, S. K., Bae, J. H., Kwon, H., & Nauck, M. A. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00435-4 · Cited by 1,061

Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

Bonaventura, A., Vecchié, A., Dagna, L., Martinod, K., Dixon, D. L., Tassell, B. W. V., Dentali, F., Montecucco, F., Maßberg, S., Levi, M. M., et al. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00536-9 · Cited by 1,039

Risk of ischemic stroke in patients with coronavirus disease 2019 (COVID-19) vs patients with influenza.

Merkler, A. E., Parikh, N. S., Mir, S., Gupta, A., Kamel, H., Lin, E., Lantos, J., Schenck, E. J., Goyal, P., Bruce, S. S., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2730 · Cited by 940

SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology

Veras, F. P., Pontelli, M. C., Silva, C. M. S., Toller-Kawahisa, J. E., de Lima, M., Nascimento, D. C., Schneider, A. H., Caetité, D. B., Tavares, L., Paiva, I. M., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20201129 · Cited by 949

Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19

Paranjpe, I., Fuster, V., Lala, A., Russak, A. J., Glicksberg, B. S., Levin, M. A., Charney, A. W., Narula, J., Fayad, Z. A., Bagiella, E., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.001 · Cited by 918

SARS-CoV-2 viral load is associated with increased disease severity and mortality

Fajnzylber, J. M., Regan, J., Coxen, K., Corry, H., Wong, C., Rosenthal, A., Worrall, D. P., Giguel, F. F., Trocha, A. K., Atyeo, C. G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19057-5 · Cited by 903

Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia

McGonagle, D., O’Donnell, J. S., Sharif, Κ., Emery, P., & Bridgewood, C. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30121-1 · Cited by 837

Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19

Woodruff, M. C., Ramonell, R. P., Nguyen, D. C., Cashman, K. S., Saini, A. S., Haddad, N. S., Ley, A. M., Kyu, S., Howell, J. C., Ozturk, T., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-00814-z · Cited by 791

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

Soy, M., Keser, G., Atagündüz, P., Tabak, F., Atagündüz, I., & Kayhan, S. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05190-5 · Cited by 837

Complement and tissue factor–enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis

Skendros, P., Mitsios, A., Chrysanthopoulou, A., Mastellos, D. C., Metallidis, S., Rafailidis, P., Ntinopoulou, M., Sertaridou, E., Tsironidou, V., Tsigalou, C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci141374 · Cited by 786

SARS-CoV-2 and Stroke in a New York Healthcare System

Yaghi, S. R., Ishida, K., Torres, J., Grory, B. M., Raz, E., Humbert, K. A., Henninger, N., Trivedi, T., Lillemoe, K., Alam, S., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.030335 · Cited by 737

Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome

Lax, S., Skok, K., Zechner, P. M., Kessler, H. H., Kaufmann, N., Koelblinger, C., Vander, K., Bargfrieder, U., & Trauner, M. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2566 · Cited by 741

The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management

Abou-Ismail, M. Y., Diamond, A., Kapoor, S., Arafah, Y., & Nayak, L. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.06.029 · Cited by 694

Characteristics of ischaemic stroke associated with COVID-19

Beyrouti, R., Adams, M. E., Benjamin, L., Cohen, H., Farmer, S. F., Goh, Y. Y., Humphries, F., Jäger, H. R., Losseff, N. A., Perry, R. J., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323586 · Cited by 711

How COVID-19 induces cytokine storm with high mortality

Hojyo, S., Uchida, M., Tanaka, K., Hasebe, R., Tanaka, Y., Murakami, M., & Hirano, T. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00146-3 · Cited by 663

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19

Zuo, Y., Estes, S. K., Ali, R. A., Gandhi, A. A., Yalavarthi, S., Shi, H., Sule, G. J., Gockman, K., Madison, J. A., Zuo, M., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abd3876 · Cited by 658

Management of acute kidney injury in patients with COVID-19

Ronco, C., Reis, T. D. A., & Husain‐Syed, F. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30229-0 · Cited by 635

Large-Scale Multi-omic Analysis of COVID-19 Severity

Overmyer, K. A., Shishkova, E., Miller, I. J., Balnis, J., Bernstein, M. N., Peters-Clarke, T. M., Meyer, J. G., Quan, Q., Muehlbauer, L. K., Trujillo, E. A., et al. (2020) · Cell Systems · doi:10.1016/j.cels.2020.10.003 · Cited by 607

The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications

McFadyen, J. D., Stevens, H., & Peter, K. (2020) · Circulation Research · doi:10.1161/circresaha.120.317447 · Cited by 600

Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence

Sardu, C., Gambardella, J., Morelli, M. B., Wang, X., Marfella, R., & Santulli, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051417 · Cited by 610

Stroke in COVID-19: A systematic review and meta-analysis

Nannoni, S., de Groot, R., Bell, S., & Markus, H. S. (2020) · International Journal of Stroke · doi:10.1177/1747493020972922 · Cited by 611

Covid-19 and autoimmunity

Ehrenfeld, M., Tincani, A., Andréoli, L., Cattalini, M., Greenbaum, A., Kanduc, D., Alijotas‐Reig, J., Zinserling, V. A., Semenova, N. Y., Amital, H., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102597 · Cited by 575

Coagulopathy of Coronavirus Disease 2019

Iba, T., Levy, J. H., Levi, M. M., Connors, J. M., & Thachil, J. V. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004458 · Cited by 541

The unique characteristics of COVID-19 coagulopathy

Iba, T., Levy, J. H., Connors, J. M., Warkentin, T. E., Thachil, J. V., & Levi, M. M. (2020) · Critical Care · doi:10.1186/s13054-020-03077-0 · Cited by 548

The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity

Osuchowski, M. F., Winkler, M. S., Skirecki, T., Cajander, S., Shankar‐Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M. W., Brunkhorst, F. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00218-6 · Cited by 528

Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper

Bhaskar, S. M. M., Sinha, A., Banach, M., Mittoo, S., Weissert, R., Kass, J. S., Rajagopal, S., Pai, A. R., & Kutty, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01648 · Cited by 524

Thromboembolic risk and anticoagulant therapy in COVID‐19 patients: emerging evidence and call for action

Κόλλιας, Α., Kyriakoulis, K. G., Dimakakos, E. P., Poulakou, G., Stergiou, G. S., & Syrigos, K. (2020) · British Journal of Haematology · doi:10.1111/bjh.16727 · Cited by 511

SARS–CoV-2 infection of the placenta

Hosier, H., Farhadian, S., Morotti, R. A., Deshmukh, U. S., Lu-Culligan, A., Campbell, K. H., Yasumoto, Y., Vogels, C. B. F., Casanovas‐Massana, A., Vijayakumar, P., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci139569 · Cited by 513

The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier

Buzhdygan, T. P., DeOre, B. J., Baldwin‐Leclair, A., Bullock, T. A., McGary, H. M., Khan, J. A., Razmpour, R., Hale, J. F., Galie, P. A., Potula, R., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105131 · Cited by 513

The SARS-CoV-2 as an instrumental trigger of autoimmunity

Dotan, A., Muller, S., Kanduc, D., David, P., Halpert, G., & Shoenfeld, Y. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102792 · Cited by 510

Convalescent plasma in Covid-19: Possible mechanisms of action

Rojas, M., Rodríguez, Y., Monsalve, D. M., Acosta‐Ampudia, Y., Camacho, B., Gallo, J. E., Rojas‐Villarraga, A., Ramı́rez-Santana, C., Díaz-Coronado, J. C., Manrique, R., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102554 · Cited by 507

COVID ‐19: A Global Threat to the Nervous System

Koralnik, I. J., & Tyler, K. L. (2020) · Annals of Neurology · doi:10.1002/ana.25807 · Cited by 480

Lifting the mask on neurological manifestations of COVID-19

Pezzini, A., & Padovani, A. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0398-3 · Cited by 447

COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation

Miesbach, W., & Makris, M. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620938149 · Cited by 456

COVID-19-associated coagulopathy and disseminated intravascular coagulation

Asakura, H., & Ogawa, H. (2020) · International Journal of Hematology · doi:10.1007/s12185-020-03029-y · Cited by 452

Severe COVID-19 infection associated with endothelial activation

Escher, R., Breakey, N., & Lämmle, B. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.014 · Cited by 440

The coagulopathy, endotheliopathy, and vasculitis of COVID-19

Iba, T., Connors, J. M., & Levy, J. H. (2020) · Inflammation Research · doi:10.1007/s00011-020-01401-6 · Cited by 441

Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation

Gu, S. X., Tyagi, T., Jain, K., Gu, V. W., Lee, S. H., Hwa, J. M., Kwan, J. M., Krause, D. S., Lee, A. I., Halene, S., et al. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00469-1 · Cited by 429

The immunology of long COVID

Altmann, D. M., Whettlock, E. M., Liu, S., Arachchillage, D. J., & Boyton, R. J. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00904-7 · Cited by 471

Targeting the NLRP3 Inflammasome in Severe COVID-19

Freeman, T. L., & Swartz, T. H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01518 · Cited by 413

The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries

Freeman, E. E., McMahon, D. E., Lipoff, J. B., Rosenbach, M. A., Kovarik, C., Desai, S. R., HARP, J. L., Takeshita, J., French, L. E., Lim, H. W., et al. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.06.1016 · Cited by 407

Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience

Bryce, C., Grimes, Z., Pujadas, E., Ahuja, S., Beasley, M. B., Albrecht, R. A., Hernandez, T., Stock, A., Zhao, Z., AlRasheed, M. R., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00793-y · Cited by 422

Thrombosis risk associated with COVID-19 infection. A scoping review

Al‐Ani, F., Chehade, S., & Lazo‐Langner, A. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.05.039 · Cited by 403

Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms

Zhou, Z., Kang, H., Li, S., & Zhao, X. (2020) · Journal of Neurology · doi:10.1007/s00415-020-09929-7 · Cited by 408

Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients

Holter, J. C., Pischke, S. E., de Boer, E., Lind, A., Jenum, S., Holten, A. R., Tonby, K., Barratt‐Due, A., Sokolova, M., Schjalm, C., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010540117 · Cited by 405

COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital

Thakur, K. T., Miller, E. H., Glendinning, M. D., Al‐Dalahmah, O., Banu, M. A., Boehme, A. K., Boubour, A., Bruce, S. S., Chong, A. M., Claassen, J., et al. (2021) · Brain · doi:10.1093/brain/awab148 · Cited by 396

Extracorporeal Life Support Organization Coronavirus Disease 2019 Interim Guidelines: A Consensus Document from an International Group of Interdisciplinary Extracorporeal Membrane Oxygenation Providers

Shekar, K., Badulak, J. H., Peek, G. J., Boeken, U., Dalton, H. J., Arora, L. L., Zakhary, B., Ramanathan, K. R., Starr, J. P., Akkanti, B. H., et al. (2020) · ASAIO Journal · doi:10.1097/mat.0000000000001193 · Cited by 385

Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis

Henry, B. M., Vikse, J., Benoit, S. W., Favaloro, E. J., & Lippi, G. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.04.027 · Cited by 381

COVID-19 and liver disease: mechanistic and clinical perspectives

Marjot, T., Webb, G. J., Barritt, A. S., Moon, A. M., Stamataki, Z., Wong, V. W., & Barnes, E. J. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00426-4 · Cited by 425

D-dimer level in COVID-19 infection: a systematic review

Rostami, M., & Mansouritorghabeh, H. (2020) · Expert Review of Hematology · doi:10.1080/17474086.2020.1831383 · Cited by 383

COVID-19-Related Stroke

Hess, D. C., Eldahshan, W., & Rutkowski, E. K. (2020) · Translational Stroke Research · doi:10.1007/s12975-020-00818-9 · Cited by 386

The complement system in COVID-19: friend and foe?

Java, A., Apicelli, A. J., Liszewski, M. K., Coler-Reilly, A. L. G., Atkinson, J. P., Kim, A. H. J., & Kulkarni, H. S. (2020) · JCI Insight · doi:10.1172/jci.insight.140711 · Cited by 392

Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition

Yu, J. M., Yuan, X., Chen, H., Chaturvedi, S., Braunstein, E. M., & Brodsky, R. A. (2020) · Blood · doi:10.1182/blood.2020008248 · Cited by 388

COVID-19 and Cardiovascular Disease

Chung, M. K., Zidar, D. A., Bristow, M. R., Cameron, S. J., Chan, T. A.-T., Harding, C. V., Kwon, D. H., Singh, T. K., Tilton, J. C., Tsai, E. J., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.317997 · Cited by 377

Neurological Involvement in COVID-19 and Potential Mechanisms: A Review

Aghagoli, G., Gallo Marin, B., Katchur, N. J., Chaves-Sell, F., Asaad, W. F., & Murphy, S. A. (2021) · Neurocritical Care · doi:10.1007/s12028-020-01049-4 · Cited by 357

Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy

Doglietto, F., Vezzoli, M., Gheza, F., Lussardi, G. L., Domenicucci, M., Vecchiarelli, L., Zanin, L., Saraceno, G., Signorini, L., Panciani, P. P., et al. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2020.2713 · Cited by 356

Mechanisms of long COVID and the path toward therapeutics

Peluso, M. J., & Deeks, S. G. (2024) · Cell · doi:10.1016/j.cell.2024.07.054 · Cited by 399

COVID-19: towards understanding of pathogenesis

Cao, W., & Li, T. (2020) · Cell Research · doi:10.1038/s41422-020-0327-4 · Cited by 344

Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19: Report of the National Institute for Public Health of the Netherlands

Oudkerk, M., Buller, H. R., Kuijpers, D., van Es, N., Oudkerk, S. F., McLoud, T. C., Gommers, D. A. M. P. J., van Dissel, J., Cate, H. T., & van Beek, E. J. R. (2020) · Radiology · doi:10.1148/radiol.2020201629 · Cited by 345

Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?

Huertas, A., Montani, D., Savale, L., Pichon, J., Tu, L., Parent, F., Guignabert, C., & Humbert, M. J. C. (2020) · European Respiratory Journal · doi:10.1183/13993003.01634-2020 · Cited by 336

COVID-19 and the Chemical Senses: Supporting Players Take Center Stage

Cooper, K. W., Brann, D. H., Farruggia, M. C., Bhutani, S., Pellegrino, R., Tsukahara, T., Weinreb, C., Joseph, P. V., Larson, E. D., Parma, V., et al. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.032 · Cited by 341

SARS-CoV-2 and the pandemic of COVID-19

Adil, M. T., Rahman, R., Whitelaw, D., Jain, V., Al‐Taan, O., Rashid, F., Munasinghe, A., & Jambulingam, P. S. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138386 · Cited by 338

Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation

Leisman, D. E., Deutschman, C. S., & Legrand, M. M. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06059-6 · Cited by 332

Extra-respiratory manifestations of COVID-19

Lai, C., Ko, W., Lee, P., Jean, S., & Hsueh, P. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106024 · Cited by 336

Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management

Anka, A. U., Tahir, M. I., Abubakar, S. D., Alsabbagh, M. Y., Zian, Z., Hamedifar, H., Sabzevari, A., & Azizi, G. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12998 · Cited by 365

Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases

Vojdani, A., Vojdani, E., & Kharrazian, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.617089 · Cited by 322

COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature

Tan, Y. K., Goh, C. M. J. L., Leow, A. S., Tambyah, P. A., Ang, A., Yap, E. S., Tu, T. M., Sharma, V. K., Yeo, L. L. L., Chan, B., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02228-y · Cited by 325

Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae

Daher, A., Balfanz, P., Cornelissen, C. G., Müller, A., Bergs, I., Marx, N., Müller‐Wieland, D., Hartmann, B., Dreher, M., & Müller, T. (2020) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106197 · Cited by 330

Autoinflammatory and autoimmune conditions at the crossroad of COVID-19

Rodríguez, Y., Novelli, L., Rojas, M., Santis, M. D., Acosta‐Ampudia, Y., Monsalve, D. M., Ramírez-Santana, C., Costanzo, A., Ridgway, W. M., Ansari, A. A., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102506 · Cited by 319

COVID‐19 and the clinical hematology laboratory

Frater, J. L., Zini, G., d’Onofrio, G., & Rogers, H. J. (2020) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13229 · Cited by 321

Vascular skin symptoms in COVID‐19: a French observational study

Bouaziz, J., Duong, T. A., Jachiet, M., Velter, C., Lestang, P., Cassius, C., Arsouze, A., Trong, E. D. T., Bagot, M., Bégon, E., et al. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16544 · Cited by 319

Mitochondria and microbiota dysfunction in COVID-19 pathogenesis

Saleh, J., Peyssonnaux, C., Singh, K. K., & Edeas, M. A. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.06.008 · Cited by 307

Autoimmune haemolytic anaemia associated with COVID‐19 infection

Lazarian, G., Quinquenel, A., Bellal, M., Siavellis, J., Jacquy, C., Ré, D., Merabet, F., MEKINIAN, A., Braun, T., Damaj, G. L., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16794 · Cited by 300

Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19

Luo, W., Li, Y., Jiang, L., Chen, Q., Wang, T., & Ye, D. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.06.007 · Cited by 294

The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China

Fu, J., Kong, J., Wang, W., Wu, M., Lin, Y., Wang, Z., Jin, J., Wu, D., & Yu, X. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.05.006 · Cited by 295

COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation

Kempuraj, D., Selvakumar, G. P., Ahmed, M. E., Raikwar, S. P., Thangavel, R., Khan, A. C., Zaheer, S. A., Iyer, S. S., Burton, C., James, D., et al. (2020) · The Neuroscientist · doi:10.1177/1073858420941476 · Cited by 302

Lupus anticoagulant is frequent in patients with Covid‐19

Harzallah, I., Debliquis, A. P., & Drénou, B. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14867 · Cited by 290

Early evidence of pronounced brain involvement in fatal COVID-19 outcomes

von Weyhern, C. H., Kaufmann, I., Neff, F., & Kremer, M. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31282-4 · Cited by 277

Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports

Najjar, S., Najjar, A., Chong, D. J., Pramanik, B. K., Kirsch, C., Kuzniecky, R., Pacia, S. V., & Azhar, S. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01896-0 · Cited by 292

Body Localization of ACE-2: On the Trail of the Keyhole of SARS-CoV-2

Salamanna, F., Maglio, M., Landini, M. P., & Fini, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.594495 · Cited by 298

The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries

Román, G. C., Spencer, P. S., Reis, J. J., Buguet, A., Faris, M. E. A., Katrak, S. M., Láinez, M. J. A., Medina, M. T., Meshram, C., Mizusawa, H., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116884 · Cited by 286

Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management

Knight, J. S., Branch, D. W., & Ortel, T. L. (2023) · BMJ · doi:10.1136/bmj-2021-069717 · Cited by 299

COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?

Colafrancesco, S., Alessandri, C., Conti, F., & Priori, R. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102573 · Cited by 278

Post-COVID-19 global health strategies: the need for an interdisciplinary approach

Gemelli Against COVID-19 Post-Acute Care Study Group, Landi, F., Gremese, E., Bernabei, R., Fantoni, M., Gasbarrini, A., Settanni, C. R., Benvenuto, F., Bramato, G., Carfì, A., et al. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01616-x · Cited by 269

Cerebral Venous Thrombosis Associated with COVID-19

Cavalcanti, D. D., Raz, E., Shapiro, M., Dehkharghani, S., Yaghi, S. R., Lillemoe, K., Nossek, E. Z., Torres, J., Jain, R., Riina, H. A., et al. (2020) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6644 · Cited by 260

p38 MAPK inhibition: A promising therapeutic approach for COVID-19

Grimes, J. M., & Grimes, K. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.05.007 · Cited by 259

Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad

Ahmed, S., Zimba, O., & Gasparyan, A. Y. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05275-1 · Cited by 251

Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research

Madhavan, M. V., Bikdeli, B., Gupta, A., Jiménez, D., Burton, J., Der-Nigoghossian, C. A., Chuich, T., Nouri, S. N., Dreyfus, I., Driggin, E., et al. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1713152 · Cited by 265

A dermatologic manifestation of COVID-19: Transient livedo reticularis

Manalo, I. F., Smith, M. K., Cheeley, J. T., & Jacobs, R. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.04.018 · Cited by 255

Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke

Saiegh, F. A., Ghosh, R., Leibold, A. T., Avery, M. B., Schmidt, R. F., Theofanis, T. N., Mouchtouris, N., Philipp, L. R., Peiper, S. C., Wang, Z., et al. (2020) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-323522 · Cited by 254

Antiviral Potential of Nanoparticles—Can Nanoparticles Fight Against Coronaviruses?

Gurunathan, S., Qasim, M., Choi, Y., Tae, J., Park, C., Hong, K., Kim, J., & Song, H. (2020) · Nanomaterials · doi:10.3390/nano10091645 · Cited by 259

ANTIPHOSPHOLIPID-LIKE SYNDROME INDUCED BY COVID19: A CASE REPORT STUDY

Marinkovic, S. P., Anastasovski, A., & Todorovska, L. (2024) · Journal of Morphological Sciences · doi:10.55302/jms2471171pm

The changes of Coagulation State in Patients Contracted with SARS-COV-19

Nosrati, A. (2020) · Iranian journal of pathology · doi:10.30699/ijp.2020.129354.2427 · Cited by 1

Antiphospholipid Antibodies in Critically Ill Patients With COVID‐19

Xiao, M., Zhang, Y., Zhang, S., Qin, X., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41425 · Cited by 174

Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients

Zhang, Y., Cao, W., Jiang, W., Xiao, M., Li, Y., Tang, N., Liu, Z., Yan, X., Zhao, Y., Li, T., et al. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02182-9 · Cited by 162

Evaluation of Antiphospholipid Antibodies in COVID-19 Patients with Coagulopathy.

Nosrati, A., Torabizadeh, Z., Kheirkhah, D., Larijani, L. V., Alizade-Navaei, R., Mobini, M., Aliyali, M., Abedi, S., & Mehravaran, H. (2022) · PubMed Central · Cited by 2